Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 356701 - 356720 out of 505060 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| Norway | (L04AC07) tocilizumab (adm: P) | RoActemra 20 mg/ml | 4 x 20 ml, Hetteglass, Konsentrat til infusjonsvæske, oppløsning, 20 mg/ml , Hetteglass | Retail price with vat |
$0-0 |
$0-0 |
Arthritis, Rheumatoid;Arthritis, Juvenile Rheumatoid;Cytokine Release Syndrome;Giant Cell Arteritis;COVID-19 virus infection | RocheRegistrationGmbH |
| Norway | (L04AC07) tocilizumab (adm: P) | RoActemra 20 mg/ml | 4 x 4 ml, Hetteglass, Konsentrat til infusjonsvæske, oppløsning, 20 mg/ml , Hetteglass | Retail price with vat |
$0-0 |
$0-0 |
Arthritis, Rheumatoid;Arthritis, Juvenile Rheumatoid;Cytokine Release Syndrome;Giant Cell Arteritis;COVID-19 virus infection | RocheRegistrationGmbH |
| Norway | (L04AC07) tocilizumab (adm: P) | RoActemra 162 mg | 4 x 0.9 ml, Ferdigfylt penn, Injeksjonsvæske, oppløsning i ferdigfylt penn, 162 mg , Ferdigfylt penn | Retail price with vat |
$0-0 |
$0-0 |
Arthritis, Rheumatoid;Arthritis, Juvenile Rheumatoid;Cytokine Release Syndrome;Giant Cell Arteritis;COVID-19 virus infection | RocheRegistrationGmbH |
| Norway | (L04AC07) tocilizumab (adm: P) | RoActemra 162 mg | 4 x 0.9 ml, Ferdigfylt sprøyte av glass, Injeksjonsvæske, oppløsning i ferdigfylt sprøyte, 162 mg , Ferdigfylt sprøyte av glass | Retail price with vat |
$0-0 |
$0-0 |
Arthritis, Rheumatoid;Arthritis, Juvenile Rheumatoid;Cytokine Release Syndrome;Giant Cell Arteritis;COVID-19 virus infection | RocheRegistrationGmbH |
| Norway | (L04AC07) tocilizumab (adm: P) | Tyenne 162 mg | 4 x 0.9 ml, Ferdigfylt penn, Injeksjonsvæske, oppløsning i ferdigfylt penn, 162 mg , Ferdigfylt penn | Retail price with vat |
$0-0 |
$0-0 |
Arthritis, Rheumatoid;Cytokine Release Syndrome;Arthritis, Juvenile Rheumatoid;COVID-19 virus infection;Giant Cell Arteritis | FreseniusKabiDeutschlandGmbH |
| Norway | (L04AC07) tocilizumab (adm: P) | Tyenne 162 mg | 4 x 0.9 ml, Ferdigfylt sprøyte av glass, Injeksjonsvæske, oppløsning i ferdigfylt sprøyte, 162 mg , Ferdigfylt sprøyte av glass | Retail price with vat |
$0-0 |
$0-0 |
Arthritis, Rheumatoid;Cytokine Release Syndrome;Arthritis, Juvenile Rheumatoid;COVID-19 virus infection;Giant Cell Arteritis | FreseniusKabiDeutschlandGmbH |
| Norway | (L04AC08) canakinumab (adm: P) | Ilaris 150 mg/ml | 1 ml, Hetteglass, Injeksjonsvæske, oppløsning, 150 mg/ml , Hetteglass | Retail price with vat |
$0-0 |
$0-0 |
Cryopyrin-Associated Periodic Syndromes;Arthritis, Juvenile Rheumatoid;Arthritis, Gouty | NovartisEuropharmLimited(1) |
| Norway | (L04AC10) secukinumab (adm: P) | Cosentyx 150 mg | 2 x 1 ml, Ferdigfylt penn, Injeksjonsvæske, oppløsning i ferdigfylt penn, 150 mg , Ferdigfylt penn | Retail price with vat |
$0-0 |
$0-0 |
Arthritis, Psoriatic;Psoriasis;Spondylitis, Ankylosing | NovartisEuropharmLimited(1) |
| Norway | (L04AC10) secukinumab (adm: P) | Cosentyx 150 mg | 2 x 1 ml, Ferdigfylt sprøyte av glass, Injeksjonsvæske, oppløsning i ferdigfylt sprøyte, 150 mg , Ferdigfylt sprøyte av glass | Retail price with vat |
$0-0 |
$0-0 |
Arthritis, Psoriatic;Psoriasis;Spondylitis, Ankylosing | NovartisEuropharmLimited(1) |
| Norway | (L04AC10) secukinumab (adm: P) | Cosentyx 300 mg | 2 ml, Ferdigfylt penn, Injeksjonsvæske, oppløsning i ferdigfylt penn, 300 mg , Ferdigfylt penn | Retail price with vat |
$0-0 |
$0-0 |
Arthritis, Psoriatic;Psoriasis;Spondylitis, Ankylosing | NovartisEuropharmLimited(1) |
| Norway | (L04AC10) secukinumab (adm: P) | Cosentyx 300 mg | 1 x 2 ml, Ferdigfylt penn, Injeksjonsvæske, oppløsning i ferdigfylt penn, 300 mg , Ferdigfylt penn | Retail price with vat |
$0-0 |
$0-0 |
Arthritis, Psoriatic;Psoriasis;Spondylitis, Ankylosing | OrifarmAS |
| Norway | (L04AC10) secukinumab (adm: P) | Cosentyx 75 mg | 0.5 ml, Ferdigfylt sprøyte av glass, Injeksjonsvæske, oppløsning i ferdigfylt sprøyte, 75 mg , Ferdigfylt sprøyte av glass | Retail price with vat |
$0-0 |
$0-0 |
Arthritis, Psoriatic;Psoriasis;Spondylitis, Ankylosing | NovartisEuropharmLimited(1) |
| Norway | (L04AD02) tacrolimus (adm: O) | Adport 0,5 mg | 50 stk, Blisterpakning, Kapsel, hard, 0,5 mg , Blisterpakning | Retail price with vat |
$0-0 |
$0-0 |
n/a | Sandoz-København |
| Norway | (L04AD02) tacrolimus (adm: O) | Advagraf 0,5 mg | 50 x 1 stk, Endoseblisterpakning, Depotkapsel, hard, 0,5 mg , Endoseblisterpakning | Retail price with vat |
$0-0 |
$0-0 |
Graft Rejection | AstellasPharmaEuropeBV |
| Norway | (L04AD02) tacrolimus (adm: O) | Advagraf 0,5 mg | 50 stk, Blisterpakning, Depotkapsel, hard, 0,5 mg , Blisterpakning | Retail price with vat |
$0-0 |
$0-0 |
Graft Rejection | AstellasPharmaEuropeBV |
| Norway | (L04AD02) tacrolimus (adm: O) | Prograf 0,5 mg | 50 stk, Blisterpakning, Kapsel, hard, 0,5 mg , Blisterpakning | Retail price with vat |
$0-0 |
$0-0 |
n/a | AstellasPharmaA/S |
| Norway | (L04AD02) tacrolimus (adm: O) | Prograf 0,5 mg | 2 x 30 stk, Blisterpakning, Kapsel, hard, 0,5 mg , Blisterpakning | Retail price with vat |
$0-0 |
$0-0 |
n/a | OrifarmAS |
| Norway | (L04AD02) tacrolimus (adm: O) | Dailiport 0,5 mg | 50 x 1 stk, Endoseblisterpakning, Depotkapsel, hard, 0,5 mg , Endoseblisterpakning | Retail price with vat |
$0-0 |
$0-0 |
n/a | Sandoz-København |
| Norway | (L04AD02) tacrolimus (adm: O) | Adport 0,75 mg | 50 stk, Blisterpakning, Kapsel, hard, 0,75 mg , Blisterpakning | Retail price with vat |
$0-0 |
$0-0 |
n/a | Sandoz-København |
| Norway | (L04AD02) tacrolimus (adm: O) | Advagraf 1 mg | 50 x 1 stk, Endoseblisterpakning, Depotkapsel, hard, 1 mg , Endoseblisterpakning | Retail price with vat |
$0-0 |
$0-0 |
Graft Rejection | AstellasPharmaEuropeBV |
Pages
